Compartilhar
Informação da revista
Vol. 45. Núm. S3.
XIV Eurasian Hematology Oncology Congress
Páginas S43-S44 (Outubro 2023)
Compartilhar
Compartilhar
Baixar PDF
Mais opções do artigo
Vol. 45. Núm. S3.
XIV Eurasian Hematology Oncology Congress
Páginas S43-S44 (Outubro 2023)
Pediatric Hematology Abstract CategoriesLeukemia PP 27
Acesso de texto completo
IS THERE AN ASSOCIATION BETWEEN PULMONARY EMBOLISM AND THE USE OF PEG-ASPARAGINASE IN CHILDREN WITH LEUKEMIA?
Visitas
303
Emine Yılmaz Orulluoğlu1, Zühre Kaya1, Merve Yazol2, Büşra Topuz Turkcan1, Serap Kirkiz Kayalı1, Ülker Koçak1,3
1 Gazi University Faculty of Medicine
2 Gazi University Faculty of Medicine, Department of Pediatric Hematology
3 Gazi University Faculty of Medicine, Department of Radiology
Este item recebeu
Informação do artigo
Suplemento especial
Este artigo faz parte de:
Vol. 45. Núm S3

XIV Eurasian Hematology Oncology Congress

Mais dados

We present two leukemic children who developed pulmonary thromboembolism (PTE) after using PEG-asparaginase.The first child, an eight-year-old boy, was diagnosed with T-acute lymphoblastic leukemia (ALL). The second child, a 6-year-old boy, was diagnosed with B-ALL.They developed PTE following induction phases of BFM protocol's.They were given PEG-asparaginase at a dose of 2500IU/m2. Heparin was succesfully used in both cases.Physician may consider prophylactic anticoagulants during induction.

O texto completo está disponível em PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Opções de artigo
Ferramentas